| 12/02/24 | 17:33:17 | 12 Feb 2024 | | Holding(s) in Company |
| 12/02/24 | 07:00:07 | 12 Feb 2024 | | Agreement with Dundee Uni and Project Initiation |
| 09/02/24 | 17:06:30 | 9 Feb 2024 | | Shareholder Requisition Notice |
| 19/01/24 | 07:00:04 | 19 Jan 2024 | | Change of Broker |
| 18/01/24 | 07:00:07 | 18 Jan 2024 | | Directorate Change |
| 04/01/24 | 13:48:32 | 4 Jan 2024 | | Result of GM, Issue of Equity |
| 19/12/23 | 18:11:11 | 19 Dec 2023 | | Result of Retail Offer, Subscription |
| 15/12/23 | 07:00:08 | 15 Dec 2023 | | Posting of Circular, Notice of GM and Ops Review |
| 13/12/23 | 16:56:26 | 13 Dec 2023 | | Retail Offer |
| 13/12/23 | 16:49:33 | 13 Dec 2023 | | Conditional Fundraise, Notice of General Meeting |
| 05/12/23 | 07:00:09 | 5 Dec 2023 | | Agreement to License VAL401 to Ambrose Healthcare |
| 10/11/23 | 07:00:08 | 10 Nov 2023 | | Evaluation Agreement with StingRay Bio |
| 06/10/23 | 10:45:59 | 6 Oct 2023 | | Statement re Share Price Movement |
| 28/09/23 | 07:00:08 | 28 Sept 2023 | | Operational Review |
| 24/08/23 | 07:00:04 | 24 Aug 2023 | | Half-year Report |
| 14/08/23 | 07:00:03 | 14 Aug 2023 | | Collaborative Services Agreement |
| 19/07/23 | 07:00:05 | 19 Jul 2023 | | Inaphaea BioLabs secures first external contract |
| 28/06/23 | 14:15:04 | 28 Jun 2023 | | Result of AGM |
| 20/06/23 | 07:00:06 | 20 Jun 2023 | | Virtual AGM Access |
| 19/06/23 | 07:00:05 | 19 Jun 2023 | | Inaphaea BioLabs Operational Update |
| 16/06/23 | 07:00:05 | 16 Jun 2023 | | Conclusion of Hokkaido Evaluation Agreement |
| 14/06/23 | 07:00:09 | 14 Jun 2023 | | Asset Purchase – Imagen Therapeutics |
| 08/06/23 | 07:00:07 | 8 Jun 2023 | | Update on proposed sub-license of VAL201 |
| 07/06/23 | 07:00:04 | 7 Jun 2023 | | Expanded agreement with University of Barcelona |
| 05/06/23 | 07:00:07 | 5 Jun 2023 | | Final Results and Notice of AGM |
| 26/05/23 | 07:00:06 | 26 May 2023 | | Notice of Results and Investor Webinar |
| 26/04/23 | 07:00:08 | 26 Apr 2023 | | Collaborative Services Agreement |
| 31/03/23 | 07:00:04 | 31 Mar 2023 | | Quarterly Operational Update |
| 01/03/23 | 07:02:01 | 1 Mar 2023 | | Investor Webinar |
| 01/03/23 | 07:00:09 | 1 Mar 2023 | | Incorporation of Inaphaea BioLabs Limited |
| 24/02/23 | 16:40:30 | 24 Feb 2023 | | Second Price Monitoring Extn |
| 24/02/23 | 16:35:20 | 24 Feb 2023 | | Price Monitoring Extension |
| 02/02/23 | 12:45:38 | 2 Feb 2023 | | Result of GM, Issue of Equity |
| 31/01/23 | 07:02:01 | 31 Jan 2023 | | Operational Update |
| 31/01/23 | 07:00:10 | 31 Jan 2023 | | Holding(s) in Company |
| 17/01/23 | 16:36:02 | 17 Jan 2023 | | Broker Offer Results |
| 17/01/23 | 09:22:51 | 17 Jan 2023 | | Posting of Circular and Notice of General Meeting |
| 13/01/23 | 07:01:01 | 13 Jan 2023 | | Launch of Broker Offer |
| 13/01/23 | 07:00:03 | 13 Jan 2023 | | Issue of Equity & Proposed Broker Offer |
| 14/12/22 | 17:01:20 | 14 Dec 2022 | | Holding(s) in Company |
| 07/12/22 | 13:06:24 | 7 Dec 2022 | | Holding(s) in Company |
| 06/12/22 | 16:40:27 | 6 Dec 2022 | | Second Price Monitoring Extn |
| 06/12/22 | 16:35:19 | 6 Dec 2022 | | Price Monitoring Extension |
| 06/12/22 | 12:00:01 | 6 Dec 2022 | | Shareholder Communications and Investor Webinar |
| 06/12/22 | 07:00:06 | 6 Dec 2022 | | Quarterly Operational and Strategy Update |
| 24/10/22 | 07:00:09 | 24 Oct 2022 | | Subsidiary Launched and IP License Signed |
| 18/10/22 | 07:00:06 | 18 Oct 2022 | | Issue of Share Options |
| 11/10/22 | 07:00:16 | 11 Oct 2022 | | Director Appointment |
| 30/09/22 | 08:47:24 | 30 Sept 2022 | | Holding(s) in Company |
| 22/09/22 | 07:00:15 | 22 Sept 2022 | | Live Shareholder Q&A and industry events |
